Otorhinolaryngological manifestations of the mucopolysaccharidoses
- PMID: 15850680
- DOI: 10.1016/j.ijporl.2005.01.017
Otorhinolaryngological manifestations of the mucopolysaccharidoses
Abstract
The mucopolysaccharidoses (MPS) are a family of related inherited metabolic disorders where, due to specific lysosomal enzyme deficiencies, partially degraded glycosaminoglycans (GAGs) accumulate in the body's cells. Due to the ubiquitous nature of GAGs in the body this deposition can occur in many tissue types and may interfere with cellular function. Although these conditions are rare, there is a propensity for the disease process to cause problems with the function of the ears, noses and throats of affected patients. In this review, we present an overview of the clinical manifestations of MPS in general and highlight the problems specifically presenting in the field of otorhinolaryngology.
Similar articles
-
Mucopolysaccharidosis: Otolaryngologic findings, obstructive sleep apnea and accumulation of glucosaminoglycans in lymphatic tissue of the upper airway.Int J Pediatr Otorhinolaryngol. 2014 Jun;78(6):944-9. doi: 10.1016/j.ijporl.2014.03.021. Epub 2014 Mar 27. Int J Pediatr Otorhinolaryngol. 2014. PMID: 24731921
-
[Hearing loss and airway problems in children with mucopolysaccharidoses].Acta Otorrinolaringol Esp. 2011 Nov-Dec;62(6):411-7. doi: 10.1016/j.otorri.2011.05.003. Epub 2011 Jul 14. Acta Otorrinolaringol Esp. 2011. PMID: 21757178 Spanish.
-
ENT and mucopolysaccharidoses.Ital J Pediatr. 2018 Nov 16;44(Suppl 2):127. doi: 10.1186/s13052-018-0555-0. Ital J Pediatr. 2018. PMID: 30442170 Free PMC article. Review.
-
Respiratory manifestations in mucopolysaccharidoses.Paediatr Respir Rev. 2011 Jun;12(2):133-8. doi: 10.1016/j.prrv.2010.10.005. Epub 2010 Nov 26. Paediatr Respir Rev. 2011. PMID: 21458742
-
Musculoskeletal manifestations of mucopolysaccharidoses.Rheumatology (Oxford). 2011 Dec;50 Suppl 5:v19-25. doi: 10.1093/rheumatology/ker397. Rheumatology (Oxford). 2011. PMID: 22210666 Review.
Cited by
-
Anaesthesia and airway management in mucopolysaccharidosis.J Inherit Metab Dis. 2013 Mar;36(2):211-9. doi: 10.1007/s10545-012-9563-1. Epub 2012 Nov 30. J Inherit Metab Dis. 2013. PMID: 23197104 Free PMC article. Review.
-
Oral manifestation and root canal therapy of the patient with mucopolysaccharidosis.Restor Dent Endod. 2019 Apr 4;44(2):e14. doi: 10.5395/rde.2019.44.e14. eCollection 2019 May. Restor Dent Endod. 2019. PMID: 31149612 Free PMC article.
-
The diagnosis and management of mucopolysaccharidosis type II.Ital J Pediatr. 2024 Oct 8;50(1):207. doi: 10.1186/s13052-024-01769-9. Ital J Pediatr. 2024. PMID: 39380047 Free PMC article. Review.
-
Hearing loss in patients with mucopolysaccharidosis II: data from HOS - the Hunter Outcome Survey.J Inherit Metab Dis. 2012 Mar;35(2):343-53. doi: 10.1007/s10545-011-9378-5. Epub 2011 Aug 25. J Inherit Metab Dis. 2012. PMID: 21866356
-
Sleep disordered breathing in mucopolysaccharidosis I: a multivariate analysis of patient, therapeutic and metabolic correlators modifying long term clinical outcome.Orphanet J Rare Dis. 2015 Apr 10;10:42. doi: 10.1186/s13023-015-0255-4. Orphanet J Rare Dis. 2015. PMID: 25887468 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources